Log in to save to my catalogue

Evaluation of a Methotrexate Chemiluminescent Microparticle Immunoassay: Comparison to Fluorescence...

Evaluation of a Methotrexate Chemiluminescent Microparticle Immunoassay: Comparison to Fluorescence...

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_proquest_miscellaneous_1803790721

Evaluation of a Methotrexate Chemiluminescent Microparticle Immunoassay: Comparison to Fluorescence Polarization Immunoassay and Liquid Chromatography–Tandem Mass Spectrometry

About this item

Full title

Evaluation of a Methotrexate Chemiluminescent Microparticle Immunoassay: Comparison to Fluorescence Polarization Immunoassay and Liquid Chromatography–Tandem Mass Spectrometry

Publisher

England

Journal title

American journal of clinical pathology, 2016-07, Vol.146 (1), p.119-124

Language

English

Formats

Publication information

Publisher

England

More information

Scope and Contents

Contents

For most laboratories, methotrexate (MTX) concentrations are routinely monitored by fluorescence polarization immunoassay (FPIA). In anticipation of an announced withdrawal of the FPIA reagent on the Abbott TDxFLx (Abbott Diagnostics, Abbott Park, IL), we have evaluated a new reagent kit developed by Abbott on the Architect i1000, based on chemilum...

Alternative Titles

Full title

Evaluation of a Methotrexate Chemiluminescent Microparticle Immunoassay: Comparison to Fluorescence Polarization Immunoassay and Liquid Chromatography–Tandem Mass Spectrometry

Identifiers

Primary Identifiers

Record Identifier

TN_cdi_proquest_miscellaneous_1803790721

Permalink

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_proquest_miscellaneous_1803790721

Other Identifiers

ISSN

0002-9173

E-ISSN

1943-7722

DOI

10.1093/ajcp/aqw088

How to access this item